ALKS
Alkermes plc.Company with tickers: ALKS
CIK
1520262
CUSIP
G01767105
Shares Outstanding
166,675,807
Website
https://www.alkermes.com
13F Activity (30d)
31 filings
7 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Christopher I. Wright, M.D., Ph.D. | director | Appointed | 2026-05-20 |
| Frank Anders Wilson | director | Appointed | 2026-05-20 |
| Nancy L. Snyderman, M.D. | director | Appointed | 2026-05-20 |
| Richard F. Pops | director | Appointed | 2026-05-20 |
| Brian P. McKeon | director | Appointed | 2026-05-20 |
| Nancy S. Lurker | director | Appointed | 2026-05-20 |
| Cato T. Laurencin, M.D., Ph.D. | director | Appointed | 2026-05-20 |
| Richard B. Gaynor, M.D. | director | Appointed | 2026-05-20 |
| Shane M. Cooke | director | Appointed | 2026-05-20 |